Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
196.13B
Market cap196.13B
Price-Earnings ratio
25.27
Price-Earnings ratio25.27
Dividend yield
2.70%
Dividend yield2.70%
Average volume
2.30M
Average volume2.30M
High today
High today
Low today
Low today
Open price
$363.08
Open price$363.08
Volume
0.00
Volume0.00
52 Week high
$391.29
52 Week high$391.29
52 Week low
$269.77
52 Week low$269.77

Stock Snapshot

As of today, Amgen(AMGN) shares are valued at $361.61. The company's market cap stands at 196.13B, with a P/E ratio of 25.27 and a dividend yield of 2.70%.

On 2026-07-13, Amgen(AMGN) shares started trading at $363.08, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 2.3M.

The stock's 52-week range extends from a low of $269.77 to a high of $391.29.

The stock's 52-week range extends from a low of $269.77 to a high of $391.29.

AMGN News

TipRanks 35m
Amgen price target raised to $312 from $307 at BofA

BofA raised the firm’s price target on Amgen (AMGN) to $312 from $307 and keeps an Underperform rating on the shares. The firm, which is updating estimates ahea...

TipRanks 2h
Analyst Maintains Sell on Amgen as Shares Trade Above Newly Raised $312 Price Target and Near-Term Growth Remains Limited

In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Sell rating on Amgen, with a price target of $312.00. TipRanks has entere...

MarketWatch 4d
Amgen Inc. stock outperforms competitors despite losses on the day - MarketWatch

...

Amgen Inc. stock outperforms competitors despite losses on the day - MarketWatch

Analyst ratings

49%

of 35 ratings
Buy
40%
Hold
48.6%
Sell
11.4%

More AMGN News

TipRanks 5d
Amgen price target lowered to $333 from $340 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Amgen (AMGN) to $333 from $340 and keeps an Equal Weight rating on the shares. Biotech could benefit from broa...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.